Qube Research & Technologies (QRT)
VECT

Qube Research & Technologies (QRT)’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-314,400
Closed -$5.3M – 4422
2023
Q2 		$5.3M Buy
+314,400
New +$4.13M 0.02% 690

Other funds holding VECT

RCM
Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VECT Position: Q3 2023 in Review

Qube Research & Technologies (QRT) sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 314,400 shares — an estimated $5.3M sold.

Qube Research & Technologies (QRT) first reported a position in VECT in Q2 2023 and held it in 1 quarter. The position peaked at $5.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

  • Qube Research & Technologies (QRT) reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 314,400 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $5.3M.
  • Qube Research & Technologies (QRT) first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s VectivBio Holding AG Ordinary Shares position peaked at $5.3M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.